Skip to Content

First Trust NYSE Arca Biotech ETF FBT

Medalist Rating as of | See First Trust Investment Hub

Morningstar’s Analysis FBT

Will FBT outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit First Trust NYSE Arca Biotech ETF to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBT

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 39.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

4.26 47.5 Mil
Healthcare

Halozyme Therapeutics Inc

4.18 46.5 Mil
Healthcare

United Therapeutics Corp

4.15 46.2 Mil
Healthcare

Corcept Therapeutics Inc

3.95 44.0 Mil
Healthcare

Vertex Pharmaceuticals Inc

3.88 43.2 Mil
Healthcare

Natera Inc

3.80 42.3 Mil
Healthcare

Incyte Corp

3.78 42.1 Mil
Healthcare

Regeneron Pharmaceuticals Inc

3.75 41.8 Mil
Healthcare

Mettler-Toledo International Inc

3.73 41.5 Mil
Healthcare

Biogen Inc

3.71 41.4 Mil
Healthcare